skip to main content
Idioma:

Variation in partial direct costs of treating clinical mastitis among 37 Wisconsin dairy farms

Leite de Campos, J ; Gonçalves, J L ; Kates, A ; Steinberger, A ; Sethi, A ; Suen, G ; Shutske, John ; Safdar, N ; Goldberg, Tony ; Ruegg, P L

Journal of dairy science, 2023-12, Vol.106 (12), p.9276-9286 [Periódico revisado por pares]

United States: Elsevier

Texto completo disponível

Citações Citado por
  • Título:
    Variation in partial direct costs of treating clinical mastitis among 37 Wisconsin dairy farms
  • Autor: Leite de Campos, J ; Gonçalves, J L ; Kates, A ; Steinberger, A ; Sethi, A ; Suen, G ; Shutske, John ; Safdar, N ; Goldberg, Tony ; Ruegg, P L
  • Assuntos: Animals ; Anti-Bacterial Agents - therapeutic use ; Anti-Infective Agents - therapeutic use ; antibiotic ; Cattle ; Cattle Diseases - drug therapy ; clinical mastitis ; cost ; dairy ; Dairying - methods ; Farms ; Female ; Lactation ; Mastitis, Bovine - drug therapy ; Milk ; Retrospective Studies ; Wisconsin
  • É parte de: Journal of dairy science, 2023-12, Vol.106 (12), p.9276-9286
  • Notas: ObjectType-Article-2
    SourceType-Scholarly Journals-1
    ObjectType-Undefined-1
    ObjectType-Feature-3
    content type line 23
  • Descrição: The objective of this observational study was to describe variations in partial direct costs of clinical mastitis (CM) treatments among 37 dairy herds using data obtained from herd management records. Animal health and drug purchase records were retrospectively collected from 37 Wisconsin dairy herds for a period of 1 yr. Each farm was visited to verify case definitions, recording accuracy, and detection criteria of CM cases. Descriptive statistics were used to summarize cost of drugs and milk discard. Differences in costs among protocols, intramammary (IMM) products, parities, days in milk, and recurrence were analyzed using ANOVA. Of 20,625 cases of CM, 31% did not receive antimicrobial treatment. The average cost of drugs and milk discard (including cases that were not treated) was $192.36 ± 8.90 (mean ± SE) per case and ranged among farms from $118.13 to $337.25. For CM cases treated only with IMM antimicrobials, milk discard accounted for 87% of total costs and was highly influenced by duration of therapy. Differences in costs were observed among parities, recurrence, and stage of lactation at case detection. Eight different treatment protocols were observed, but 64% of cases were treated using only IMM antimicrobials. Treatment costs varied among protocols; however, cases treated using both IMM and injectable antimicrobials as well as supportive therapy had the greatest costs as they were also treated for the longest duration. Ceftiofur was used for 82% of cases that received IMM antimicrobials while ampicillin was used for 51% of cases treated using injectable antimicrobials. With the exception of ceftiofur and pirlimycin IMM products, many IMM products were given for durations that exceeded the maximum labeled duration. For cases treated using only IMM therapy, as compared with observed costs, we estimated that partial direct costs could be reduced by $65.20 per case if the minimum labeled durations were used. Overall, partial direct costs per case varied among herds, cow factors, and treatment protocols and were highly influenced by the duration of therapy.
  • Editor: United States: Elsevier
  • Idioma: Inglês
Links
Voltar para lista de resultados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.